The instinct when a buyer hears "private equity is in this market" is to assume the game is over — that institutional capital will outbid every independent. On whole-agency deals at scale, that's often true. But the fractional market is a different game, and PE mostly isn't playing it. Understanding why turns "we can't compete with PE" into a precise map of where independents win.
§ 01 · The PE playbookThree constraints, and the math behind them.
PE buys insurance agencies at roughly 4.5×–6.5× EBITDA, targeting a 20%+ internal rate of return over a four-to-five-year hold, then an exit. That math only works above a scale threshold — a $1M-EBITDA agency is a viable PE target; a $150K-EBITDA agency is not, because the management layer the model requires can't be supported. The playbook rests on three constraints. The first is scale-driven economics: operational leverage requires scale. The second is whole-book acquisition: PE buys whole agencies to avoid partial-integration complexity and client-fracture risk. The third is the consolidation thesis: the roll-up needs agencies large enough to support a management overlay — a 500-policy agency supports it, a 50-policy book doesn't. These three constraints aren't weaknesses; they're what makes the model work at scale. But they define, precisely, the deals PE can't profitably touch.
§ 02 · The three categories PE skipsWhere the gap is.
PE's absence from the fractional market is a playbook limitation, not a capital limitation — and that limitation is the independent buyer's advantage. PE systematically underweights three categories: sub-scale whole-agency deals, fractional carve-outs from larger agencies, and highly specialized books. Each is too small, too partial, or too specialized to fit a consolidation thesis. That mismatch is the gap.
Three categories fall outside the playbook. The first is sub-scale whole-agency deals — a $300K-EBITDA agency that's a real opportunity for an independent but isn't a PE target. The second is fractional carve-outs from larger agencies — PE buys wholes, not pieces, so a defined slice of a bigger book is a non-starter for the model. The third is highly specialized books — a 200-policy high-net-worth personal book or a specialty commercial vertical creates integration friction for a roll-up but is a clean fit for an independent who already operates in that niche. PE leaves these on the table because they don't fit the consolidation thesis, not because the returns are bad. The mechanism is an asymmetry: PE's path to return is a roll-up that requires scale infrastructure, and fractional slices are too small, too specialized, or too operationally fragmented to ride that path. The hidden-market dynamics this asymmetry creates are covered in PE competition and the hidden market.
§ 03 · Three ways independents winFit, portfolio, relationships.
| SMA buyer strategy | Capital deployed | Core competency |
|---|---|---|
| Play a different game | $200K–$500K, repeatedly over 12–24 months | Superior slice diligence + fractional relationships |
| Win on fit | $500K–$2M, used opportunistically | Line, geography, or customer overlap as the fit anchor |
| Build a portfolio | $1M+, patient deployment | Systematic integration; 3 years compounds to a whole-agency book |
Independents win with three strategies. Play the fit game: target slices where your existing business creates operational synergy — fit drives retention and integration ease, an advantage PE can't replicate from the outside. Build a portfolio over time: three $40K slices over 18 months is a perfectly valid path — it spreads risk, lets you test before a larger commitment, and compounds expertise. Leverage relationships, not just capital: existing customers, producers, carrier appointments, and local markets produce returns PE's playbook structurally can't incorporate. These map to three buyer-strategy archetypes that have emerged — the buyer who plays a different game (modest capital deployed repeatedly), the buyer who wins on fit (moderate-to-substantial capital used opportunistically), and the buyer who builds a portfolio (substantial, patient capital whose three-year aggregate rivals a traditional acquisition).
§ 04 · The positioning ruleDon't play PE's game.
The decisive rule is what not to do: don't try to compete with PE on full-agency deals at scale. PE will likely win on price, and independents will likely lose on capital efficiency — it's not the game to play. The competitive advantage is not capital; it's fit, relationships, and time horizon. PE runs a 4–5 year hold optimized for a transformative exit; independents run an 18–36 month book-building horizon where acquisitions compound. So the strategic-positioning move is to build the thesis around existing strengths — a geographic specialist targets geographic slices, a line-of-business specialist targets matching slices, a relationship-first operator targets customer-overlap slices. Existing fit is the moat. Played that way, PE's presence in the broader market stops being a threat and becomes the reason the fractional slices keep showing up unbid. Which archetype you are, and how to position against each of the others, is in buyer archetypes.
◆
Terminology on this shelf
- Consolidation thesis
- The roll-up logic behind PE agency buying — it requires agencies large enough to support a management overlay.
- Scale threshold
- The EBITDA level below which the PE model stops working — roughly $1M is a target, $150K is not.
- Fractional carve-out
- A defined slice carved from a larger agency's book — PE buys wholes, so these fall outside the playbook.
- The fit game
- Targeting slices where your existing book creates operational synergy — an advantage PE can't replicate.
- PE-slice asymmetry
- PE's roll-up needs scale; fractional slices are too small or specialized to ride it — so PE leaves them on the table.
- Book-building horizon
- The independent's 18–36 month frame where smaller acquisitions compound — versus PE's 4–5 year exit hold.